Effects of chicory and fumitory on hot flashes in postmenopausal women; a prospective non-randomized single arm clinical trial

Introduction: Hot flashes are the most common annoying symptom in menopause and impair the quality of life in postmenopausal women. Objectives: The present study aimed to assess the effects of a product prepared from chicory and fumitory on hot flashes in postmenopausal women. Patients and Methods: This prospective non-randomized single arm clinical trial study was performed on 43 postmenopausal women with hot flashes. After recording the number and severity of hot flash episodes on a daily basis for one week, an herbal product made of chicory and fumitory was administered for four weeks (5 cc in the morning and 5 cc at night), and they completed the form designed for the daily record of hot flashes. Results: In the week before the intervention, most episodes were severe, and there was only one day without hot flashes among patients. The number and severity of hot flash episodes decreased significantly within 1 to 4 weeks after the intervention, compared to the period before the treatment. Moreover, the mean number of severe and very severe episodes decreased significantly, while the mean number of mild episodes increased during the study period. Furthermore, with the progress of the study, the number of days without hot flashes in patients increased significantly. Conclusion: Based on the results of our study, the use of chicory and fumitory was effective in the improvement of the number and severity of hot flash episodes, and the effect was observed one week after administration. Trial Registration: This trial protocol was approved by the Iranian Registry of Clinical Trial (identifier: IRCT20160722029027N13; ethical code; IR.SBMU.MSP.REC.1398.460).

Authors

Institutions

Publication Details

Journal
Immunopathologia Persa
Published
2025-04-20
DOI
https://doi.org/10.34172/ipp.2025.43821
Primary Topic
Menopause: Health Impacts and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of chicory and fumitory on hot flashes in postmenopausal women; a prospective non-randomized single arm clinical trial

Ladan Ajori, Mojgan Tansaz, Leila Nazari, Roya Gharedaghi et al.
Immunopathologia Persa
Menopause: Health Impacts and Treatments
article

Effects of chicory and fumitory on hot flashes in postmenopausal women; a prospective non-randomized single arm clinical trial

Ladan Ajori, Mojgan Tansaz, Leila Nazari, Roya Gharedaghi, Mozhgan Mehri, Fereshteh Gharedaghi
article en

Abstract

Introduction: Hot flashes are the most common annoying symptom in menopause and impair the quality of life in postmenopausal women. Objectives: The present study aimed to assess the effects of a product prepared from chicory and fumitory on hot flashes in postmenopausal women. Patients and Methods: This prospective non-randomized single arm clinical trial study was performed on 43 postmenopausal women with hot flashes. After recording the number and severity of hot flash episodes on a daily basis for one week, an herbal product made of chicory and fumitory was administered for four weeks (5 cc in the morning and 5 cc at night), and they completed the form designed for the daily record of hot flashes. Results: In the week before the intervention, most episodes were severe, and there was only one day without hot flashes among patients. The number and severity of hot flash episodes decreased significantly within 1 to 4 weeks after the intervention, compared to the period before the treatment. Moreover, the mean number of severe and very severe episodes decreased significantly, while the mean number of mild episodes increased during the study period. Furthermore, with the progress of the study, the number of days without hot flashes in patients increased significantly. Conclusion: Based on the results of our study, the use of chicory and fumitory was effective in the improvement of the number and severity of hot flash episodes, and the effect was observed one week after administration. Trial Registration: This trial protocol was approved by the Iranian Registry of Clinical Trial (identifier: IRCT20160722029027N13; ethical code; IR.SBMU.MSP.REC.1398.460).

Immunopathologia PersaVol. 11
Islamic Azad University Medical Branch of Tehran (IR), Jahrom University of Medical Sciences (IR), Alborz University of Medical Sciences (IR), Shahid Beheshti University of Medical Sciences (IR)
Openalex Percentile: Top 85%
Menopause: Health Impacts and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.